Inteligencia artificial en salud: Paola Rivero de AstraZeneca en el podcast de Arkangel AI

Listen to the Episode →

Artificial Intelligence in Health Innovation: Arkangel AI & AstraZeneca Insights

Discover how Arkangel AI and AstraZeneca are pioneering artificial intelligence in health across Latin America. Featuring AstraZeneca’s Innovation Digital Lead, this episode reveals key collaborations and actionable strategies for healthcare’s digital future.

Episode Title: Scaling Real-World Impact—AstraZeneca’s Digital Hubs & Arkangel AI Redefine Artificial Intelligence in Health

This episode with Arkangel AI and AstraZeneca unveils how artificial intelligence in health transforms diagnostics, connects healthcare ecosystems, and advances patient outcomes in Latin America.

Summary

Host Laura Velasquez from Arkangel AI speaks with Paola Rivero, Digital Innovation Lead for Latin America at AstraZeneca. They discuss collaborative models, AstraZeneca’s innovation hubs, and how artificial intelligence in health is unlocking faster diagnoses and new partnerships in the region.

Episode at a Glance

• Guests: Paola Rivero — Digital Innovation Lead LATAM, AstraZeneca
• Topics: Innovation hubs, AI for early diagnosis, collaboration models, data integration, real-world implementation
• Why it matters for artificial intelligence in health: Collaboration and technology now enable earlier diagnoses, addressing unmet needs in Latin America’s health systems, and advancing patient-centric solutions.

Overview

Artificial intelligence in health is rewriting the rules of patient care, especially in regions with persistent barriers to early diagnosis and health data integration. In this episode, host Laura Velasquez from Arkangel AI and guest Paola Rivero from AstraZeneca explore why collaboration—across pharma, startups, government, and academia—is crucial for scaling true innovation.

Paola reveals AstraZeneca’s model of establishing regional innovation hubs, first launched in Colombia, and now expanding in Latin America. These hubs bring together key players (including organizations like Arkangel AI) to adapt global health advancements to local needs, accelerating the deployment of AI-powered tools for patient benefit. The episode delivers concrete strategies for practitioners and health leaders navigating digital transformation in complex systems.

Key Takeaways

• Early diagnostic accuracy improves patient outcomes and reduces health system costs.
• Collaboration between pharma, startups, and government accelerates technology adoption.
• Integrated data systems and AI enable scalable, personalized healthcare solutions.
• Regulatory clarity and life-cycle maintenance of AI tools are critical for sustainable impact.

Chapter Markers

• [00:00] Why innovation matters in health: Arkangel AI and AstraZeneca’s vision
• [05:12] Building cross-sector collaboration models
• [14:37] Implementing AI for early diagnostics in Latin America
• [22:09] Practical barriers: data, regulation, and sustainable adoption

Notable Ideas

• “Artificial intelligence is now the best ally for meeting urgent health needs.” — Paola Rivero, AstraZeneca
• “You need to connect solutions quickly, not spend a year on planning—because in a year, everything changes.” — Paola Rivero, AstraZeneca
• “Technology needs to be coupled with clinical knowledge for effective implementation.” — Laura Velasquez, Arkangel AI

Why This Matters

For clinicians and healthcare leaders, artificial intelligence in health unlocks faster diagnostics, improved risk stratification, and actionable insights within tight clinical timeframes. AstraZeneca’s approach, rooted in collaborative innovation hubs, exemplifies how industry can catalyze rapid AI pilot deployment, closing gaps between research and patient care.

Medical affairs teams and system administrators gain strategies for integrating AI tools—like those developed by Arkangel AI—into local ecosystems, addressing data silos and regulatory barriers. These advances translate into timely interventions, better resource allocation, and measurable improvements in regional health outcomes.

About Arkangel AI

Arkangel AI leverages artificial intelligence in health to optimize and scale diagnostic pathways for healthcare organizations across Latin America. Through data-driven tools and strategic collaborations (including with AstraZeneca and leading public institutions), Arkangel AI delivers practical solutions for early diagnosis, clinical decision support, and health system strengthening, tailored to the regional context.

FAQ

• Q: How does artificial intelligence in health improve early disease diagnosis in Latin America?

  A: By integrating AI algorithms with clinical and population data, organizations like Arkangel AI and AstraZeneca’s hubs enable faster identification of underdiagnosed diseases (such as COPD), supporting clinicians to act earlier and reducing costly late-stage treatments.

• Q: What makes AstraZeneca’s innovation hubs unique in advancing artificial intelligence in health?

  A: AstraZeneca’s hubs link startups, government, academia, and pharma to identify local health challenges and adapt global AI solutions, enabling tailored, scalable tools for diagnostics and patient education. No other pharma has such region-specific, cross-sector innovation models.

• Q: What are the main barriers to AI adoption in health systems?

  A: Episode experts highlight fragmented data, regulatory gaps, limited collaboration, and sustainability planning for AI tools as top challenges. Strategic cross-sector cooperation is essential to overcome these hurdles.

• Q: How can clinicians and administrators ensure sustainable AI implementation?

  A: Leaders should prioritize transparent collaboration, regulatory alignment, ongoing tool evaluation, and active integration into clinical workflows, as modeled by Arkangel AI and AstraZeneca.

• Q: Where can I learn more about successful AI collaborations in health?

  A: Visit Arkangel AI or AstraZeneca’s innovation page for case studies and practical frameworks relevant to Latin America.